Agilis announces Intrexon deal, CEO and financing

Newco Agilis Biotherapeutics LLC (Germantown, Md.) announced a deal with synthetic biology company Intrexon Corp. (NYSE:XON), named a new

Read the full 197 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE